E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects-Reference-Cited by-同舟云学术

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects

Published:2021-12-22 Issue:24 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Sharma Shailza,Watanabe Tomoya^ORCID,Nishimoto Tetsuya,Takihara Takahisa,Mlakar Logan,Nguyen Xinh-Xinh,Sanderson Matthew,Su Yunyun,Chambers Roger A.,Feghali-Bostwick Carol^ORCID

Funder

NIH/NHLBI

NIH/NIAMS

The SmartState and Kitty Trask Holt Endowment

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/144935/files/pdf

Reference44 articles.

1. Review: Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis: How Similar and Distinct?

2. Epidemiology and Natural History of Systemic Sclerosis

3. Changes in causes of death in systemic sclerosis, 1972-2002

4. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

5. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P4HB regulates the TGFβ/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells;BMC Nephrology;2024-09-09

2. IGF-II regulates lysyl oxidase propeptide and mediates its effects in part via basic helix-loop-helix E40;Matrix Biology;2024-09

3. The collagen history;Biochemistry of Collagens, Laminins and Elastin;2024

4. Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis;Respiratory Research;2023-11-14

5. The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches;Basic Research in Cardiology;2023-11-08